An extraordinary medicine price increase could add R1bn to medical schemes’ costs in 2027, after schemes submitted their budgets.
The Health Department announced the additional 2.88% single exit price (SEP) adjustment on 30 September, effective from 1 October. It cited cost pressures for pharmaceutical manufacturers, including geopolitical tensions.
Continue reading with a Health Matters subscription
Subscribers read every article in full, receive the daily briefing and have access to the complete archive.
